AGM
CALA

Alpine Global Management’s Calithera Biosciences, Inc CALA Stock Holding History

Alpine Global Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-775
Closed -$57K – 185
2016
Q2 		$57K Buy
+775
New +$77.6K 0.03% 163

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MMPI
Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpine Global Management's CALA Position: Q3 2016 in Review

Alpine Global Management sold out of Calithera Biosciences, Inc (CALA) in Q3 2016, closing a stake of 775 shares — an estimated $57K sold.

Alpine Global Management first reported a position in CALA in Q2 2016 and held it in 1 quarter. The position peaked at $57K in Q2 2016. 40 funds tracked by Wall St. Rank hold CALA as of Q3 2016.

  • Alpine Global Management reported no remaining Calithera Biosciences, Inc position as of Q3 2016 after selling out during the quarter.
  • Alpine Global Management sold 775 Calithera Biosciences, Inc shares in Q3 2016, an estimated $57K.
  • Alpine Global Management first reported a position in Calithera Biosciences, Inc in Q2 2016 and held it in 1 quarter.
  • Alpine Global Management's Calithera Biosciences, Inc position peaked at $57K in Q2 2016.
  • 40 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2016.

Based on Alpine Global Management's 13F filing for Q3 2016, filed 15 Nov 2016.